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Recent outbreak of ﬂavivirus Zika virus (ZIKV) in America has urged the basic as well as translational
studies of this important human pathogen. The nonstructural protein 5 (NS5) of the ﬂavivirus has an N-
terminal methyltransferase (MTase) domain that plays critical roles in viral RNA genome capping. The
null mutant of NS5 MTase is lethal for virus. Therefore, NS5 is a potential drug target for the treatment of
Zika virus infection. In this study, we determined crystal structures of the ZIKV MTase in complex with
GTP and RNA cap analogue 7meGpppA. Structural analyses revealed highly conserved GTP/cap-binding
pocket and S-adenosylmethionine (SAM)-binding pocket. Two conformations of the second base of
the cap were identiﬁed, which suggests the ﬂexibility of RNA conformation. In addition, the ligand-
binding pockets identiﬁed a continuous region of hotspots suitable for drug design. Docking calcula-
tion shows that the Dengue virus inhibitor compound 10 may bind to the ZIKV MTase.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Zika virus (ZIKV), which was declared as a public health emer-
gency of international concern (PHEIC) by the World Health Orga-
nization (WHO) on February 1st, 2016, has attracted broad
attention. ZIKV, a member of the ﬂaviviridae genus family, is mainly
spread by Aedes mosquitoes [1]. Although most cases of ZIKV
infection produce no symptoms, this virus may be associated with
various severe neural disorders, including a brain defect in
newborn called microcephaly, which occurs in pregnant women
infected with ZIKV [2,3] and an autoimmune disease known as
GuillaineBarre syndrome (GBS) [4e6]. A recent report by Li et al.
has provided the ﬁrst demonstration that ZIKV infection directly
affects neural precursor cell (NPC) development in a murine model
and may lead to the development of microcephaly [7]. Although
recent reports on vaccine development in animal study showed
promising results [8], no vaccine or anti-viral drugs are available for
the ZIKV. Therefore, the investigation of molecular mechanisms of
ZIKV pathogenesis and the development of anti-viral vaccines orInc. This is an open access article u
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unications (2016), http://dxinhibitors is extraordinarily urgent. We are particular interested in
the structural and functional characterization of key ZIKV viral
proteins toward the goal of ZIKV antiviral development.
The ZIKV genome is initially translated into a single polyprotein
precursor, which is further processed into three structural proteins
(capsid [C], membrane precursor [M] and envelope [E] proteins)
and seven nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A,
NS4B and NS5) by host and viral proteases [9]. Among these pro-
teins, the NS5 is the largest and most conserved nonstructural
protein that contains a S-adenosyl-L-methionine (SAM)-dependent
methyltransferase (MTase) at its N-terminus and a RNA-dependent
RNA polymerase (RdRP) at its C-terminus. It plays critical roles in
viral genome replication with its RdRP and genome RNA capping
with MTase domain respectively.
Ray et al demonstrated that the West Nile virus (WNV) NS5
MTase mediates both guanine N-7 and ribose 20-O methylations in
a sequential manner in the ﬂavivirus RNA type 1 cap m7
GpppAm2
0 O G formation. Both of the reactions use SAM as a
methyl donor, with the ﬁrst reaction only requires D146 while the
later one requires the entire K61-D146-K182-E218 motif [10]. In
addition, it can further methylate internal adenosines of the viral
RNA genome and potentially host RNA at the ribose 20-OH position
[11]. The function of 20-O methylation of viral RNA cap is to mimicnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The N-7 methylation of RNA cap is critical for efﬁcient translation,
and dominant negative mutant of MTase that abolish N-7 methyl-
ation was lethal for ﬂavivirus replication [13]. As a result, the NS5
MTase is an attractive target for anti-viral therapies. Designing
ﬂavivirus-selective inhibitors have been challenging due to the
high conserved core domains of various MTase. Despite of that,
ﬂavivirus MTase-speciﬁc inhibitors have been designed against the
NS5 MTase of Dengue virus using structure-based approaches
[14,15].
The NS5 MTase is a bi-substrate enzyme, which has speciﬁc
binding sites for both RNA and SAM. It also shares the binding site
for GTP and RNA cap. The complex structures with substrates/
products are available for some ﬂaviviruses, and the ZIKV NS5
MTase structure bound with SAM and 7meGpp ligand was solved
recently [16], the ZIKV:RNA cap analogue complex structure is still
unavailable. To provide detailed structural information to better
understand the molecular function of this important enzyme, and
to aid design of antiviral drugs against ZIKV, we determined the
GTP-SAH bound structure and the cap analogue 7meGpppA-SAH
complex structure of ZIKV NS5 MTase at 2.05 Å and 2.45 Å
respectively. We further did molecular docking calculations to
probe druggable hotsopts and to study small molecule drugs-
MTase interactions.
2. Material and methods
2.1. Cloning, expression and puriﬁcation
The coding region of NS5 gene of a ZIKV strain isolated in
Hangzhou 2016 (gb: AMM39806) was synthesized by General
Biosystem (Chuzhou, China). Its NS5 methyltransferase region was
ampliﬁed by PCR and ligated into aMBP tagged expression vector in
a pET30a backbone. The recombinant MBP fusion protein was
expressed in E.coli and puriﬁed as described for other proteins [17].
After a TEV protease cleavage, the tag free MTase was obtained by a
second step Ni-NTA puriﬁcation followed by a 5 ml HiScreen™
Phenyl FF (high sub) (GE healthcare, USA) hydrophobic chroma-
tography puriﬁcation in buffer A and buffer B (buffer A: 1.0 M
(NH4)2SO4, 20 mM Tris-HCl pH 7.5, buffer B: 20 mM Tris-HCl pH
7.5). The ﬁnal protein sample is a single band by revealed by SDS-
PAGE.
2.2. Crystallization, data collection and structure determination
The ZIKV NS5MTase proteinwas concentrated to over 30 mg/ml
and crystallization conditions were screened with available com-
mercial as well as in-house designed crystallization kits. Several
hits were readily identiﬁed within 2e7 days after the set-up of
hanging drops. High quality crystals were obtained with a condi-
tion containing 0.1 M (NH4)2SO4, 10% PEG8000, 0.1 M SPG buffer (a
mixture of succinic acid, sodium dihydrogen phosphate and glycine
in the molar ratios 2:7:7) pH 7.0. 20% PEG200 and 10% glycerol in
addition to the crystallization condition was used as cryo-
protective solution to ﬂash-cool the crystals in liquid nitrogen. In
order to obtain ligand bound structures, we did soaking experi-
ments by adding ligands of 5 mM each into crystallization drops
containing single crystals. For the GTP complex structure, only GTP
ligand was used. While for the RNA cap analogue complex struc-
ture, a combination of 7meGpppA (Sigma) and SAH were used. The
crystals were picked after overnight soaking. 5 mM ligands were
included in cryo-protectant solutions to improve electron density
of ligands.
X-ray diffraction data were collected at the SSRF beamline
BL18U and BL-19U1. A typical data set of 180 images were collectedPlease cite this article in press as: C. Zhang, et al., Structure of the NS5 m
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processed with xds [18], and the space group was determined to be
P61. Data analysis by Xtriage [19] in the Phenix package identiﬁed
large Patterson peak of 50% height relative to origin, suggesting the
presence of translational pseudo symmetry. The results of the L-test
indicate that the data is exactlymerohedral twinning. The structure
was determined by molecular replacement calculation with phaser
[20] using the MVEV MTase structure (pdb 2PX2) [19] as a
searching template. The structural model was improved by rounds
of manual model ﬁtting in coot [21] and structural optimization in
phenix reﬁne with a twin speciﬁc target function (h, -h-k, -l) in
Phenix GUI [22]. The ﬁnal structural models were validated by the
Molprobity server [22] and RCSB ADIT validation server [23].
2.3. Identiﬁcation of potential small molecule binding pocket
We used the FTmap server [24] (http://ftmap.bu.edu/) and
metaPocket 2.0 server [25] to identify druggable hotspots of ZIKV
NS5-MTase. The hotspots are cavities on the protein surface that
represent potential ligand-binding sites.
2.4. Docking calculation of NS5 MTase with an inhibitor (compound
10)
Based on the high similarity of the ZIKV and DENV MTase
structures, we performed molecular docking calculation of the
identiﬁed DENV inhibitor compound 10 with our ZIKV MTase by
AutoDock4.2 (http://autodock.scripps.edu/) [26]. The DENV MTa-
se:inhibitior complex structure (PDB ID: 3P8Z) [15] is adapted in
our simulation calculation.
2.5. Accession codes
Coordinates and structure factors have been deposited in the
Protein Data Bank, and the accession codes are 5GOZ for GTP-SAH
bound structure and 5GP1 for the 7meGpppA-SAH complex struc-
tures respectively. Data collection and reﬁnement statistics are
listed in Table 1.
3. Results
3.1. Protein expression, crystallization and structure determination
The recombinant ZIKV NS5 MTase domain was expressed in
Escherichia. coli and puriﬁed to high homogeneity (Fig. S1). Ac-
cording to the results of size-exclusion chromatography, the pro-
tein existed as a monomer in solution (Fig. S1D). The crystals
diffracted to 2.05e2.5 Å resolutions (Table 1). The ZIKV MTase
structures were solved by molecular replacement despite of severe
twinning.
3.2. Overall structure of GTP-SAH complex
There are three molecules in one asymmetric unit. It exhibits
typical features of SAM-dependent MTases in the ﬂavivirus family,
and adopts a Rossmann fold with 8 a-helices and 9 b-sheets (Fig. 1A
and Fig. S2. Although we did not add SAM/SAH in the GTP complex
crystal, a SAH molecule is identiﬁed in the structure. Both GTP and
SAH have unambiguous density and can be modeled completely.
The GTP-SAH bound structure was reﬁned to 2.05 Å and yielded a
ﬁnal Rwork of 23.6% and Rfree of 26.3% (Table 1). The ﬁnal model in
one asymmetric unit contained 784 residues from three molecules,
four GTP and three SAH molecules, and 156 water molecules. No
SAM/SAH was added to the crystal of the MTase: GTP complex,
electron density still clearly shows a SAHmolecule instead of a SAMethyltransferase from Zika virus and implications in inhibitor design,
.doi.org/10.1016/j.bbrc.2016.11.098
Table 1
X-ray data collection and reﬁnement table.
GTP-SAH 7meGpppA-SAH
Spacegroup P61 P61
Unit cell (a, b, c) (Å) 123.8123.8, 120.1 123.8, 123.8, 119.4
(a,b,g) () 90, 90, 120 90, 90, 120
Resolution (Å)a 50e2.05 (2.17e2.05) 50e2.44 (2.59e2.45)
No. of reﬂections (total/unique) 653980/65414 311408/38127
Redundancya 10.0 (10.2) 8.2 (7.7)
Completeness (%)a 99.8 (99.2) 99.1 (95.8)
I/s(I)a 14.3 (1.8) 12.3 (2.0)
R-meas (%)b,a 10.2 (149.3) 18.2 (108.3)
CC(1/2) (%)a 99.9 (64.0) 99.8 (86.6)
Reﬁnement
Resolution (Å) 50e2.05 50e2.45
No. of protein atoms 6123 6085
No. of solvent/hetero-atoms 156/264 70/342
Rmsd bond lengths (Å) 0.004 0.003
Rmsd bond angles () 1.08 0.60
Rwork (%)c 23.6 23.7
Rfree (%)d 26.3 28.0
Ramachandran plot (favored/disallowed)e 95.9/0 96.3/0
PDB code 5GOZ 5GP1
a Asterisked numbers correspond to the last resolution shell.
b Rmeas ¼ Sh(n/n-1)1/2 Si jIi(h) -<I(h)> j/ShSi Ii(h), where Ii(h) and <I(h)> are the ith and mean measurement of the intensity of reﬂection h.
c Rwork ¼ ShjjFobs (h)j-jFcalc (h)jj/ShjFobs (h)j, where Fobs (h) and Fcalc (h) are the observed and calculated structure factors, respectively. No I/s
cutoff was applied.
d Rfree is the R value obtained for a test set of reﬂections consisting of a randomly selected 10% subset of the data set excluded from reﬁnement. R
and Rfree are high for 2e2.5A resolution, may due to twinning data or data quality.
e Values from Molprobity server (http://molprobity.biochem.duke.edu/).
Fig. 1. Overall structure of the ZIKV NS5 MTase domain. (A) Ribbon representation of GTP-SAH complex. The MTase is colored in teal with major secondary structure components
labeled. Its termini, SAM -binding site, GTP/cap-binding site and the putative ssRNA-binding groove are indicated. (B) Structural comparison of ﬂavivirus family viral NS5 MTases.
The ZIKV structure is in lime. MTases from JEV (4K6M), MVEV (2PX2), DENV (1L9K), WNV (2OY0), YFV (3EVA), Wesselsbron virus (3ELD) and Yokose virus (3GCZ) are magenta,
yellow, orange, cyan, light tint, grey and slate, respectively. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this
article.)
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puriﬁcation of SAH is common for the ﬂaviviral MTase [27].
3.3. Structural comparison
The sequence identities between the ZIKV NS5 MTase and those
from WNV, Japanese encephalitis virus (JEV), MVEV, DENV and
yellow fever virus (YFV) are 70%, 70%, 69%, 61% and 55%, respec-
tively (Fig. S2 and Table S1). The superposition of the ZIKA NS5 GTP-Please cite this article in press as: C. Zhang, et al., Structure of the NS5 m
Biochemical and Biophysical Research Communications (2016), http://dxSAH bound structure with those of other ﬂavivirus family showed
nearly identical structures (Fig. 1B). The RMSD values of Ca based
structure alignment lies between 0.42 Å and 0.47 Å (Table S1).
3.4. SAM/SAH-binding pocket
There is one SAH molecule in both GTP complex and 7meGpppA
complex structures. The SAH molecule ﬁts into a conserved SAM-
binding pocket by a network of hydrogen bonds and van derethyltransferase from Zika virus and implications in inhibitor design,
.doi.org/10.1016/j.bbrc.2016.11.098
Fig. 2. SAH and GTP bound complex structure. (A) Ball-and-stick representation of the SAM-binding pocket bound with SAH. (B) 2Fo-Fc electron density map of SAH ligand
calculated at 1.5s. (C) GTP/cap-binding pocket bound with GTP. (D) 2Fo-Fc electron density map of GTP ligand calculated at 2s.
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proteins.3.5. GTP complex structure
It is intriguing for us to ﬁnd out how GTP and RNA cap bind to
the ZIKV MTase. Structural analysis of GTP complex reveals a highly
conserved binding mode for GTP in the GTP/cap binding site. The
GTP molecule has close interactions with the ﬁrst two helices
namely a1 and a2, and the guanine base forms parallel stacking
with the aromatic ring of conserved residue F24 (Fig. 2CeD). The 2-
amine group of guanine forms hydrogen bonding with main chain
carbonyl groups of L16, N17 and M19, which functions as a struc-
tural determinant of speciﬁc guanine binding despite of its
methylation status of the N7 position. The ribose adopts a 3’-endo
conﬁguration. The 2’-hydroxyl group of ribose interacts via
hydrogen bonding with side chain of N17 and K13. Its 3’-hydroxyl
group is hydrogen -bonded via a solvent molecule with the main
chain nitrogen atom of S151. Unexpectedly, we found some extra
density on the surface of one MTase molecule. Since 5 mM of GTP
was included in the overnight soaking solution and in cryoprotec-
tant solution, we modeled this density as a GTP (Fig. S3). Whether
this second GTP binding site merely comes from crystallization artifact
still awaits future investigations.Please cite this article in press as: C. Zhang, et al., Structure of the NS5 m
Biochemical and Biophysical Research Communications (2016), http://dx3.6. Structure of RNA cap analogue complex
In order to get insight into structural requirement of cap
recognition by the ZIKV NS5 MTase, we soaked the RNA cap
analogue 7meGpppA and SAH into the “native” crystals. Structure
analysis showed that the protein did not undergo signiﬁcant
structural changes after the binding of the RNA cap, which only has
a RMSD of 0.38 Å compared with the GTP bound complex. Three
copies of 7meGpppA molecules were built in an asymmetric unit
with three copies of NS5 MTase. All of the three tri-phosphate
linkers in one asymmetric unit adopt a U shape. Considering the
hydrogen bonding networks and electron density, we ﬁt the N7
methylated guanine into the guanine binding pocket identiﬁed in
our GTP complex, and leave the second adenine out which has two
conformations in the three copies of molecules in one asymmetric
unit. The adenine takes a stacked conformation in chain A
(Fig. 3AeB), which is almost perfectly parallel to the ﬁrst guanine
and aromatic ring of F24. The 2’- and 3’- hydroxyl groups are
exposed, which allows the 3’- hydroxyl groups to engage into a 3' to
5' phosphosdiester bond. While in chain B and chain C, the adenine
nucleobase is near perpendicular to the ﬁrst guanine (Fig. 3CeD),
and its 2’- and 3’- hydroxyl groups are facing the main chain of
S150-S151 loop, whichmake it inaccessible to extend the RNA chain
through 3' OH group.ethyltransferase from Zika virus and implications in inhibitor design,
.doi.org/10.1016/j.bbrc.2016.11.098
Fig. 3. RNA cap complex reveals different conformations. (A) Parallel conﬁguration of the RNA cap analogue 7meGpppA. The protein is colored in teal and RNA cap is colored in
lemon. (B) 2Fo-Fc electron density map of the parallel RNA cap analogue 7meGpppA contoured at 2s. (C) Perpendicular conﬁguration of the RNA cap analogue 7meGpppA. The RNA
cap is colored in ruby (D) Superposition of the GTP and two 7meGpppA RNA cap ligands in two different conformations. The GTP molecule (including tri-phosphate) is colored in grey
for clarity. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 4. Identiﬁcation of drug-binding hotspots and inhibitor docking calculation. (A) MetaPocket result ﬁle of all the predicted pocket sites are shownwith red mesh. The site 1
and site 2 are corresponding to SAM/SAH- binding site and GTP/RNA binding site respectively. (B) Chemical structure of DENV inhibitor compound 10. (C) Superposition of the
complex structure of DENV MTase (green): compound 10 (green) (pdb 3P8Z) with Zika MTase (cyan): compound10 (magenta) (by docking calculation). (For interpretation of the
references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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We predicted hotspots for potential small molecule drug bind-
ing with the FTmap program and metaPocket 2.0 server. Three
inter-connected regions (Site 1e3, Fig. 4A) were identiﬁed, among
them site 1 is equivalent to the SAM binding site (Site 1 and Site 2 is
equivalent to the GTP/RNA cap-binding site. Importantly, there is a
pocket (Site 3) mixed with hydrophobic and polar characteristics,
lies in the middle of Site 1 and Site 2, which is suitable for in silico
high-throughput small molecule screening. Considering the con-
nectivity of the three sites, it is possible to design a high afﬁnity
inhibitor to occupy the majority of the cavity.
Inspired by the high conservation of ZIKV MTase structure, we
want to explore the possible interactions with known ﬂaviviral
MTase inhibitors. Our docking calculation shows that a previously
identiﬁed DENV inhibitor, compound 10 (Fig. 4B), may bind to ZIKV
MTase while with lower afﬁnity (Table S2, Fig. 4C). Our modeling
study based on the ZIKV MTase structure provides important clues
for the design of novel inhibitors against the ZIKV MTase3.
4. Conclusion and discussion
In summary, we are reporting the crystal structures of ZIKV
MTase that is critical for viral genome replication and immune
evasion. We determined two tertiary complexes of ZIKV MTase
bound with GTP and a SAH or RNA cap analogue 7meGpppA and a
SAH. Both structures exhibit highly conserved features for both of
the ﬁrst guanosine nucleotide of RNA cap and SAM-binding
pockets. The high-degree structural conservation of this non-
structural gene product is in agree with the critical biological
functions it plays for virus survival. It also set a basis for our search
of anti-ZIKV compounds based on inhibitors to other viruses.
Indeed, broad-spectrum antivirals targeting the ﬂavivirus MTase
have been reported [28].
In addition, we observed the adenine base of RNA cap analogue
adopted two conformations. In fact, two different cap analogue
conformations have been reported for the MTase of DENV [29], in
both of which, the second base forms parallel stacking with the ﬁrst
base. Besides of the parallel conformation, we identiﬁed a
perpendicular conformation (Fig. 3CeD), which has not been re-
ported before. The ﬂexibility of cap conformation suggests that in
transition state, RNA could adopt difference conformations to
facilitate the methyl transfer reaction.
Lastly, our crystal structure identiﬁed a druggable pocket suit-
able for inhibitor design. Lim et al. found that a small molecule
inhibitor named compound 10 that selectively block DENV MTase,
but not host hRNMT or hDNMT. In addition, compound 10 could
also inhibit WNV MTase, but with less potency [15]. Mechanisti-
cally, the selective inhibition of compound 10 against DENV MTase
is obtained through binding of the N6 benzylic ring to the identiﬁed
pocket. The binding of compound 10 in DENV MTase induced its
side chain rotation of F133 and R163, to accommodate its N6-
substituted aryl ring [15]. A strong cation-p interaction forms be-
tween residue Arg163 and the N6-aryl ring of compound 10, which
contributes to the binding free energy in DENV MTase [15]. Due to
the high sequence and structural similarity of ZIKV and DENV,
based on our docking calculation, we propose that the DENV in-
hibitor compound 10 is a good starting point for ZIKV inhibitor
design.
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